Sanofi set to launch $15bn jumbo loan imminently

France’s Sanofi-aventis is expected to launch a $15bn syndicated loan into syndication on Tuesday after initiating an $18.5bn hostile bid for US biotech firm Genzyme on Monday.

  • 04 Oct 2010

BNP Paribas, JPMorgan and Société Générale have underwritten the facility on an equal basis. It comprises a $10bn 18 month ‘A’ tranche with a six month extension option at the borrower’s behest and a $5bn 3-1/2 year ‘B’ piece.

“This will be launched imminently, perhaps tomorrow,” said a banker ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 1,284 2 30.09
2 Barclays 633 1 14.82
3 BNP Paribas 509 1 11.91
4 Citi 467 1 10.94
5 Morgan Stanley 455 1 10.66

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 10,064.23 34 12.48%
2 Barclays 7,915.37 23 9.82%
3 Bank of America Merrill Lynch 7,473.95 24 9.27%
4 JPMorgan 7,314.30 26 9.07%
5 Wells Fargo Securities 6,484.83 25 8.04%